tiprankstipranks
Advertisement
Advertisement

VRTX Stock Latest News

Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
Market NewsLooking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
20h ago
BLK
IBB
Vertex Pharmaceuticals price target raised to $615 from $607 at Barclays
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $615 from $607 at Barclays
3d ago
VRTX
Vertex Pharmaceuticals announces Casgevy reimbursement agreement
PremiumThe Fly
Vertex Pharmaceuticals announces Casgevy reimbursement agreement
3d ago
VRTX
Vertex Pharmaceuticals price target raised to $616 from $612 at Morgan Stanley
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $616 from $612 at Morgan Stanley
5d ago
VRTX
Vertex Pharmaceuticals price target raised to $543 from $541 at RBC Capital
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $543 from $541 at RBC Capital
5d ago
VRTX
Analyst Maintains Hold on Vertex as Strong CF Franchise Offsets Mixed Q1 Results and Non‑CF Pipeline Uncertainty
PremiumRatingsAnalyst Maintains Hold on Vertex as Strong CF Franchise Offsets Mixed Q1 Results and Non‑CF Pipeline Uncertainty
5d ago
VRTX
Vertex Pharmaceuticals price target lowered to $436 from $437 at Canaccord
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $436 from $437 at Canaccord
5d ago
VRTX
Vertex Pharmaceuticals price target lowered to $572 from $577 at Bernstein
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $572 from $577 at Bernstein
5d ago
SION
VRTX
Vertex Pharmaceuticals Earnings Call Highlights New Growth Engines
PremiumCompany Announcements
Vertex Pharmaceuticals Earnings Call Highlights New Growth Engines
5d ago
VRTX
Closing Bell Movers: Pinterest jumps 15% on earnings beat; Palantir slips
PremiumThe Fly
Closing Bell Movers: Pinterest jumps 15% on earnings beat; Palantir slips
5d ago
FN
ON
Moderna updates on Cystic Fibrosis collaboration with Vertex Pharmaceuticals
PremiumThe Fly
Moderna updates on Cystic Fibrosis collaboration with Vertex Pharmaceuticals
5d ago
MRNA
VRTX
Vertex Pharmaceuticals reports Q1 EPS $4.02, consensus $4.31
PremiumThe Fly
Vertex Pharmaceuticals reports Q1 EPS $4.02, consensus $4.31
5d ago
VRTX
Vertex Pharmaceuticals affirms FY26 revenue $12.95B-$13.1B, consensus $13.05B
PremiumThe FlyVertex Pharmaceuticals affirms FY26 revenue $12.95B-$13.1B, consensus $13.05B
5d ago
VRTX
Vertex options imply 5.5% move in share price post-earnings
Premium
The Fly
Vertex options imply 5.5% move in share price post-earnings
6d ago
VRTX
Notable companies reporting after market close
Premium
The Fly
Notable companies reporting after market close
6d ago
ON
PGR
These Are the Stocks Reporting Earnings Today – May 4, 2026
PremiumMarket News
These Are the Stocks Reporting Earnings Today – May 4, 2026
6d ago
L
ON
Options Volatility and Implied Earnings Moves Today, May 04, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, May 04, 2026
6d ago
ON
RIG
The Week That Was, The Week Ahead: Macro and Markets, May 3
PremiumMarket News
The Week That Was, The Week Ahead: Macro and Markets, May 3
7d ago
C
F
Vertex Pharmaceuticals Inc. (VRTX) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Vertex Pharmaceuticals Inc. (VRTX) Q1 Earnings Cheat Sheet
8d ago
VRTX
Vertex Pharmaceuticals price target lowered to $437 from $441 at Canaccord
PremiumThe FlyVertex Pharmaceuticals price target lowered to $437 from $441 at Canaccord
10d ago
VRTX
Vertex Director Upadhyay to Step Down Amid CFO Move
Premium
Company Announcements
Vertex Director Upadhyay to Step Down Amid CFO Move
10d ago
8K
VRTX
Vertex: Crowded IgAN Market and Gradual Povetacicept Adoption Keep Rating at Hold, Price Target Unchanged at $441
Premium
Ratings
Vertex: Crowded IgAN Market and Gradual Povetacicept Adoption Keep Rating at Hold, Price Target Unchanged at $441
11d ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >